Arthritis Foundation of America releases recommendations on CBD use for joint pain
The American Arthritis Foundation, which represents 50 million adults suffering from some form of arthritis, has just publish its recommendations for people wishing to try CBD, a first for such a patient advocacy group.
These recommendations aim to clarify the use of CBD. The group does not recommend its use, but notes that people with arthritis show «significant interest in CBD» for pain relief.
«It was important to recognize public interest and release guidance on the state of the science,» said Kevin Boehnke, a researcher in anesthesiology at the University of Michigan. «Our recommendations don't say, »You should try this.» They say, «If you want to try this, here's how you should do it.»".
CBD products have become widely available in the United States after the passage of the Farm Bill, which legalized hemp at the federal level, and therefore the extraction and use of CBD.
The Arthritis Foundation interrogated more than 2,600 patients, and found that 791 of them are taking CBD, have taken it, or are considering taking it for their joint pain. She notes, however, that there is anecdotal scientific evidence of the effectiveness of CBD on pain, and encourages further scientific research.
While these studies are being conducted, she suggests that patients:
- Start with low doses and gradually increase while monitoring symptoms. The same applies to adding THC in states where it is legal.
- to set up a medical protocol with their doctor
- to obtain them from well-known and recognized brands that provide certificates of analysis for their products
- to avoid vaping CBD, particularly for individuals suffering from inflammatory arthritis
- to inquire about CBD interactions with other medications
The Foundation does not recommend any particular product.
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange
-
Cannabis in Africa1 week ago
Kenya Denies Rastafarians the Right to Use Cannabis


You must be logged in to post a comment Login